Benchmark dose (BMD) analysis is generally recognized superior to generate a point of departure (PoD) to conduct risk assessment on environmental toxicants, comparing with the traditionally employed no observed adverse effect level (NOAEL) or lowest observed adverse effect level (LOAEL) methods. However, only a few studies compared the two on producing PoD of thyroid toxicity caused by environmental chemicals. Here, we presented BMD analyses on several thyroid toxicity endpoints caused by a model chemical -propylthiouracil (PTU). Adult female rats underwent ovariectomy were randomly assigned into groups receiving different doses of PTU (0, 0.1, 0.5, 1.0, and 5.0 mg/kg bw) through gavage for 8 days. Results show that PTU induces significant dose-dependent changes of serum total thyroxine (tT 4 ), total triiodothyronine (tT 3 ), thyroid stimulating hormones, liver type I 5′-deiodinonase (5′-DI) and malic enzyme (ME) activity with profound histopathological exacerbation. BMD and BMDL results (0.03 and 0.01 mg/kg bw respectively) from Hill model of liver 5′-DI activity were accepted based on selection criteria in the benchmark dose analysis. In summary, BMD analysis results in much lower PoD (0.01 mg/kg bw) than LOAEL (0.1 mg/kg bw) in PTU induced thyroid toxicity.
Introduction
Thyroid is an endocrine organ that is essential in both normal development and metabolic regulation of living organisms (Mullur et al., 2014) . Thyroid disorder and diseases have become a pandemic that induce tremendous social and economic burden. Particularly, the increase of thyroid cancer incidence was much higher than any other malignancy in the last two decades (Vigneri et al., 2015) . Etiological studies indicated that many environmental toxicants have been associated as causes of thyroid diseases (Zoeller, 2010; Liu et al., 2017) . Thus, risk assessment of environmental toxicant induced thyroid toxicity would better guide future preventative strategies in environmental health.
In risk assessment, a point of departure (PoD) is of great importance as it is the dose level to infer acceptable risk to a certain hazard. PoD marks the level where an estimated lowest observed adverse effect level or no observed adverse effect level, usually known as LOAEL or NOAEL, was determined in a dose-response curve (EPA, 1993) . However, the LOAEL and NOAEL methods fail to adequately reflect all information in a dose-response relationship and sample size to extract accurate PoD; they usually fall in the gap between 0 and the actual dose of causing significant effects (Crump, 1995) . An alternative method, benchmark dose (BMD) analysis, provids insights to overcome these limitations by utilizing advanced statistical tools to generate PoD (EFSA, 2009) . BMD is defined as a dose or an exposure that can cause a prescribed effect in response, known as benchmark dose response (BMR) (Crump, 1995; EFSA, 2009) . The statistical lower limit of BMD (BMDL) is usually considered as the PoD in risk assessment.
Propylthiouracil (PTU), a known thyroid function inhibitor, can suppress thyroid peroxidase activity, leading to reduced production of thyroglobulin and thyroxine (T 4 ) (Taurog, 1976) . Thus, PTU should serve as a perfect model chemical to study thyroid toxicity. In the present study, the ovariectomized (OVX) rats were exposed to PTU and samples were collected to measure total T 4 (tT 4 ), total Triiodothyronine (tT 3 ), thyroid stimulating hormones (LeVine et al., 2001) , type I 5′-deiodinonase (5′-DI), malic enzyme (ME) and histopathology. BMD analysis was employed to screen the most sensitive endpoints and to produce the lowest PoD.
Materials and methods

Chemicals and reagents
PTU (≥ 99% purity), sucrose, and Dowex WX200-400 ion exchange https://doi.org/10.1016/j.yrtph.2018.06.013 Received 17 April 2018; Received in revised form 11 June 2018; Accepted 16 June 2018 T 3 (rT 3 ) was purchased from Beijing North Biotechnology Institute (Beijing, China). Reverse T 3 (≥ 96% purity) was purchased from Toronto Research Chemicals (Toronto, Canada). Pierce BCA protein assay kit was obtained from Thermo-Fisher (Rockford, IL, USA).
Animals
Female Sprague Dawley albino rats free of specific pathogens were purchased from Huafukang Bioscience Co. Ltd. (Beijing, China). The animals were housed singly in cages under controlled temperature (20-24°C) and humidity (40-70%) with a 12-h light/dark cycle and air change of 10 times per hour. Animals were fed with soy and alfalfa free diet (Huafukang Bioscience, Beijing, China) and provided with unlimited purified water throughout the study. The study was approved by the Institutional Animal Care and Use Committee (IACUC) of China National Center for Food Safety Risk Assessment. All experimental procedures were carried out according to the Guidance for the Care and Use of the Animals Management Rules of the Ministry of Health of the People's Republic of China.
Study design
Before the experiment, animals were acclimated to the environment for 7 days. All 50 rats then received bilateral ovariectomy with a twelve-day recovery phase. Sham control, where animals received the surgery without removing ovaries, was not included in this experiment as the same animal model was successfully established in our previously published paper (Chen et al., 2015) . Animals were randomly allocated into 5 groups (Control, 0.1, 1.0, 5.0 and 10.0 mg/kg•bw of PTU) based on their body weight. All animals were given either corn oil for control or PTU suspended in corn oil through daily gavage for 8 consecutive days. The animals were observed for any clinical signs of impairment and their body weight was recorded every two days. All animals were fasted for 12 h before the euthanasia with sodium pentobarbital (50 mg/kg•bw). Blood was collected from abdomen aorta and centrifuged at 3000 rpm for 10 min to obtain serum. Slices from right liver lobe weighting about 1 g were immediately rinsed with PBS and frozen with liquid nitrogen. Thyroids were dissected and preserved in 4% paraformaldehyde.
Liver 5′-DI activity assay
As previously described (Chen et al., 2015) , liver tissue was homogenized in ice-cold buffer (320 mM sucrose, 1.0 mM dithiothreitol (DTT), 10 mM HEPES buffer, pH 7.0) at a 1:39 wt/volume ratio. The suspensions were centrifuged (3000 × g) at 4°C for 10 min to collect supernatant. 1 mL buffer was added to the centrifuged pellets and suspended thoroughly and recentrifuged (20,000 × g) at 4°C for 10 min. The supernatant was collected and combined with that from the first centrifugation. 20 μL supernatant was incubated with a buffer (0.005 μM [
125 I] rT 3 , 0.495 μM rT 3 , 2 mM DTT, 1 mM EDTA, 10 mM PBS, pH 7.0) at 37°C. The reaction was stopped by adding 200 μL cold T 4/ PTU solution. The stopped reaction solution was centrifuged through a filter loaded with Dowex acidic ion exchange resin at 1500 × g for 5 min. The filters were eluted twice with 1.0 mL 10% acetic acid and all supernatants were collected and used to measure the released 125 I − ion in a gamma counter (Xi'an Nuclear Instrument Factory, Shanxi, China). Counts per minutes (CPM) were recorded and normalized with total protein concentrations for all supernatant using Pierce BCA protein kit.
Liver malic enzyme activity assay
The method of measuring ME activity was described previously with some minor modifications (Schmutzler et al., 2004) . Liver was homogenized on ice at a w:v = 1:10 ratio in a buffer containing 0.25 mM sucrose, 50 mM Tris-HCl, 0.1 mM EDTA, pH = 7.4. Homogenate was centrifuged at 15,000 g for 10 min at 4°C. Supernatant was collected for total protein assay and malic enzyme activity assay. 200 μL of reaction buffer (67 mM triethanolamine, 1.5 mM L-malic acid, 4 mM MnCl 2 , and 0.5 mM NADP + , pH = 7.4) was added in 96 well plate. 20 μL of liver sample supernatant or homogenate buffer as control was added in the reaction buffer. Absorbance was measured at 340 nm every 31 s for 7 times in each sample well. NADPH concentration was determined by applying NADPH (10-500 μM) standards. The speed of NADPH formation ( Δ Δt e ) was calculated based on 7-time results. The ME activity was labeled as μmol NADPH per mg protein per min under equation:
Total reaction volume
Sample volume protein concentration ME activity Δ Δt e
Serum thyroid hormones
Serum levels of tT 3 and tT 4 were measured using a radioimmunoassay kit (North Biotechnology Institute, Beijing, China). Serum TSH level was determined by an ELISA assay kit (Endocrine Technology, Newark, CA, USA). All experiments were carried out according to the manufacturers' protocols.
Histopathology and morphometry
Thyroid weight and thyroid/body weight ratio was recorded and calculated. Fixed thyroid tissues were embedded in paraffin wax and sectioned at approximately 46 μm. Sections were then deparaffinized and stained with hematoxylin and eosin (H&E) for histopathologic and morphologic analysis. An area ratio of thyroid follicular epithelium/ colloid was measured and calculated as described previously (Chen et al., 2015; Schmutzler et al., 2007) .
BMD analysis
Benchmark dose software (BMDS) version 2.4 (EPA, Washington D.C., USA) was used for dose-response relationship analysis. Mean, standard deviation (SD), and sample size of each endpoint were imputed to calculate BMD and BMDL. Benchmark dose (BMD) and benchmark dose lower limit (BMDL) was generated based on following modeling criteria from EPA (EPA, 2012):
➢ Because all quantitative endpoints are continuous in the study, we apply each dataset to all five available continuous model options in BMDS (polynomial, exponential, hill, linear, and power model). ➢ Dataset will be excluded from modeling if: 1) the dose-response relationship curves is drastically "wavy or bumpy", because such variances are very unlikely to occur from a biological point of view; 2) the tested endpoint shows no significant change (P > 0.05) at any treatment doses comparing with control. ➢ Benchmark dose response (BMR) will be defined as 1 SD of control group for continuous data. Evidence has shown BMR of 1 SD of control group for continuous data is quantitatively similar 10% extra risk as BMR for categorical data (Crump, 1995) . ➢ Models were statistically accepted when P value is greater than 0.10.
Among these accepted models for each endpoint, the one with the smallest akaike information criterion (AIC) value was considered most fit (EFSA, 2009). Finally, the most appropriate BMD and BMDL were the smallest set among all endpoints.
Statistics
One-way analysis of variance (ANOVA) was used to determine the statistical difference among groups and a Dunnett T test or a least square difference (LSD) test was used for pair-wise comparison between any two groups based on the homogeneity of variance results. The differences were significant when P < 0.05. Data were presented as mean ± SD.
Results
Body weight and clinical observations
Rats received OVX surgery 13 days prior to PTU exposure (Fig. 1A ), during which a dose of 20,000 units of penicillin were given to animals which need relief from inflammatory symptoms due to the surgery. All animals recovered from the surgery and showed no obvious clinical symptoms at the beginning of the PTU dosing. Initial body weight, terminal body weight, and body weight change were not significantly different among all treatment groups (Fig. 1B, C, D) .
Changes of thyroid hormone levels in response to PTU
Serum tT 3 levels significantly decreased as the PTU dose increases. The increase plateaued at the highest doses of PTU (1.0 and 5.0 mg/kg bw) ( Fig. 2A) . Similarly, compared with that in control rats, serum tT 4 of the PTU treated decreased significantly with a dose-dependent trend (Fig. 2B) . Serum TSH levels significantly increased in animals treated with any doses of PTU compared with those in control. The increase of serum TSH reached the highest level at 0.1 mg/kg bw (Fig. 2C). 3.3. Liver 5′-DI and ME activity levels decreased by PTU All doses of PTU significantly decreased liver 5′-DI activity compared with that of the control rats with a dose-dependent manner (Fig. 3A) . However, changes of liver ME activity by PTU seemed less evident than that of 5′-DI activity. Only low (0.1 mg/kg bw) and high (5.0 mg/kg bw) doses of PTU significantly decreased liver ME activity while medium doses (0.5 and 1.0 mg/kg bw) only induced a trend of reduction (Fig. 3B) .
Thyroid histopathological changes to PTU
All PTU treatment induced thyroid histopathological changes; and the tissue damage exacerbated with the increase of PTU dose. As shown in Fig. 4E , thyroid tissue of control rat displays consistent follicle structure with a layer of low-column epithelium cells rounded in shape and their cytoplasm is basophilic. Epithelial-cell formed follicles were Fig. 3 . Liver 5′-DI enzyme (A) and ME (B) activity of OVX rats were changed by different doses of PTU treatment. One-way ANOVA with post hoc pair-wise comparison was used to differentiate the statistical difference (P < 0.05). Fig. 4 . Histopathological changes of thyroids of PTU-treated OVX rats (HE stains). OVX rats were given PTU at 0.1 (A), 0.5 (B), 1.0 (C), 5.0 (D) mg/kg bw, and control (E) for 8 consecutive days. : congestion of capillary vessels between thyroid follicles. : reduced or disappeared colloid. : deformed, deciduous and necrotic epithelium cells of thyroid follicles. Fig. 5 . Thyroid/body weight ratio (A) and thyroid follicular/colloid area ratio (B) of OVX rats were changed by different doses of PTU treatment. One-way ANOVA with post hoc pair-wise comparison was used to differentiate the statistical difference (P < 0.05). similar in size and shape and filled with light-pink colloid. Thyroid tissue was mildly affected by PTU at 0.1 mg/kg bw where only minor colloid decrease was observed (Fig. 4A) . Animals in PTU 0.5 mg/kg bw group started to show congestion in the blood capillary between thyroid follicles and decreased colloid within thyroid follicles (Fig. 4B) . PTU (1.0 mg/kg bw) induced hypertrophy and deformed and deciduous cells of follicular epithelium. The colloid was significantly decreased or even disappeared (Fig. 4C) . Besides above abnormalities, thyroids of the rats in 5.0 mg/kg bw group showed loosened follicular epithelial structures with massive deformed and deciduous epithelium cells, colloid disappearance, and red blood cell infiltration (Fig. 4D) .
Quantitative pathological data indicates that PTU (0.5, 1.0, 5.0 mg/ kg bw) caused significant increase of thyroid/body weight ratio comparing with that of the control, except for the 0.1 mg/kg bw dose group (Fig. 5A) . While all PTU dose groups showed substantial increased follicular epithelium/colloid ratio (Fig. 5B) .
Benchmark dose modeling of all endpoints
All 7 tested endpoints (tT 3 , tT 4 , TSH, 5′-DI activity, ME activity, thyroid/body weight ratio, and thyroid follicular/colloid ratio) showed significant change by at least one PTU dose. Dose-response relationships for each endpoint showed monotonic change with a few minor bumpy fluctuations (e.g. ME activity). We decided to consider ME activity for BMD modeling because the overall trend was decreasing (Fig. 3B) . Thus, all 7 endpoints were included in the benchmark dose modeling.
As shown in Table 1 , the goodness of fit test results failed to accept any model for either tT 3 or ME activity datasets (P < 0.10). Thus, there won't be BMD and BMDL results for the two endpoints. Hill model was most suitable and statistically accepted (P > 0.10 and the lowest AIC) for serum tT 4 (P = 0.27, AIC = 316), TSH (P = 0.37, AIC = 264), 5′-DI activity (P = 0.96, AIC = 79), and thyroid/body weight ratio (P = 0.27, AIC = 94). Besides, polynomial model was most fit for thyroid follicular/colloid ratio data (P = 0.31, AIC = −49). All doseresponse relationship curves for the fit models were presented in Fig. 6 . BMD and BMDL were also calculated for the accepted model of each endpoint respectively. As displayed in Table 2 , the difference between lowest and highest BMD or BMDL can be as large as 18 times (e.g. BMDL of 0.18 mg/kg bw for thyroid follicular/colloid ratio vs. 0.01 mg/ kg bw for 5′-DI activity). Based on the selection criteria, the lowest set of BMD and BMDL values (0.03 and 0.01 mg/kg bw) would be accepted and the lower bound of BMD (BMDL), 0.01 mg/kg bw, will be used as PoD for PTU-induced thyroid toxicity.
Discussion
As a proven inhibitor of thyroid function, PTU is used as a prescribed drug to cure thyroidal diseases such as hyperthyroidism (Patrick et al., 2002) . Because of its potency to induce inhibitory dose-response effects on thyroid, PTU can serve as a perfect model chemical of thyroid toxicity at relatively low doses (Yamasaki et al., 2002 ). OVX rat model has been widely employed to study endocrine disruption by environmental chemicals in experimental settings (O'Connor et al., 1999) . Ovariectomy can at large minimize the interference of estrogen on thyroidal endpoints because evidence indicates that estrogen can bind to ubiquitously present estrogenic receptors in hypothalamus-pituitarythyroid (HPT) axis to cause feedback response on thyroid (Arain et al., 2003) . Our previous studies have shown that a OVX rat model was successfully established (Chen et al., 2015 (Chen et al., , 2016 .
The thyroid toxicity results caused by PTU in the present study are consistent with those found in the literature (Taurog, 1976; Yamasaki et al., 2002; Chen et al., 2016; Mellert et al., 2003) . The toxicity of PTU is characterized with increased TSH and decreased T 3 and T 4 levels (Yamasaki et al., 2002) . Mechanistically, PTU downregulates thyroid peroxidase (TPO) activity, which inhibits the incorporation of iodine into tyrosyl residues of thyroglobulin, an essential protein for the synthesis of T 4 (Taurog, 1976; Chen et al., 2016) . Decreased T 4 can directly lead to reduced T 3 production, which is the biologically active form of the thyroid hormone (Harvey and Williams, 2002) . A negative feedback loop on the HPT axis would respond to the decreased T 4 /T 3 levels and lead to increased TSH levels (Harvey and Williams, 2002) . Increased TSH levels stimulate compensatory hyperplasia of thyroid tissue and trigger all the histological changes presented in the results.
Both liver 5′-DI and ME activity levels were recommended as sensitive endpoints to investigate thyroid toxicity by environmental chemicals (Schmutzler et al., 2007) . In the liver, enzymatic activity of 5′-DI is vital for the transformation of T 4 to T 3 , where 5′-DI is the enzyme to either convert T 4 to T 3 through removing an iodine atom from the 5′ position on the "outer ring", or inhibit the activation by removing iodide from the 5′ position which is on the "inner ring" (Schmutzler et al., 2007) . Significantly decreased 5′-DI activity by PTU in our experiment indicated a slowed-down process of T 3 production. T 3 can cast its metabolic influence through liver ME as its activity is highly associated with T 3 levels and it plays important role in lipid metabolism by providing NADPH for fatty acid biosynthesis (Goodridge et al., 1996) . Our results of liver 5′-DI and ME activity corroborated both hormonal and histological changes reflecting thyroid toxicity by PTU.
The main aim of the study was to investigate the PoD of thyroid toxicity by PTU using a BMD method. BMD analysis has been proven better than the traditional methods such as NOAEL and LOAEL to generate the PoD (Crump, 1995) . NOAEL/LOAEL is usually determined based on the tested doses and largely dependent on the study design and data quality (Chen et al., 2015) . For example, if the dosimetry leaves a big gap between LOAEL and 0 mg/kg bw, it will be hard to determine NOAEL, not to mention the true point of departure for the toxicity (Crump, 2002) . On the other hand, BMD utilized all dose information and produce an estimated PoD based on the dose-response relationship (EFSA, 2009) . The calculated benchmark dose also reflects a hypothetical toxic response, benchmark dose response (BMR), to determine a relative risk from the control, where BMR is usually defined as 10% extra risk for dichotomous dataset or 1 standard deviation (SD) of control mean for continuous data (EPA, 2012) . Because all datasets are continuous in our case, we applied 1 SD of control mean as Note: a denotes accepted modeling when P > 0.10. Bold texts indicate accepted model based on AIC criteria. Fig. 6 . Models that were accepted for each endpoint. Hill model were most suitable for serum tT 4 (A), TSH (B), liver 5′-DI activity (C), and thyroid/body weight ratio (D). Polynomial model was accepted for thyroid follicular/colloid area ratio (E). Model was accepted based on statistical standards (P > 0.05 and the lowest AIC).
the BMR in the present study. As the PoD from BMD analysis, BMDL can be considered as a LOAEL since its corresponding BMR is still a toxic effect (EPA, 2012) . However, the BMDL is more protective in terms of generating a lower and more accurate PoD (BMDL 0.01 mg/kg bw vs. LOAEL 0.1 mg/kg bw).
We want to generate the lowest reference point possible to be most conservative and protective in terms of risk assessment. Because of the high potency of PTU to inhibit thyroid function, all the endpoints (serum tT 3 , tT 4 , TSH, liver 5′-DI activity, liver ME activity, thyroid/ body weight ratio, and thyroid follicular/colloid area ratio) are very sensitive at the tested doses with the same LOAEL at 0.1 mg/kg bw. Studies have investigated endocrine disrupting effects by PTU in various experimental settings. One investigated PTU endocrine modulating effects based on the "Enhanced OECD Test Guideline 407" where LOAEL was also 0.1 mg/kg bw based on both thyroid/body weight ratios (female rats) and increased serum TSH level (male rats) (Mellert et al., 2003) . The PoD found in our study is also in consistence with current literature body where the lowest tested PTU dose at 0.01 mg/kg bw was determined as NOAEL (Yamasaki et al., 2002) . One experiment employed an OECD (Organization for Economic Co-operation and Development) standard protocol to investigate the thyroid toxicity of PTU, showing a NOAEL at 0.01 mg/kg bw and LOAEL at 1.0 mg/kg bw based on serum T 3 and T 4 levels readouts (Yamasaki et al., 2002) . However, the inconsistence of LOAEL or NOAEL reflects the limitations of the NOAEL/LOAEL methods as they largely depend on how the doses are designed.
Conclusions
The results from the present study indicate that PTU is a strong thyroid function inhibitor that can induce significant effects at very low dose. BMD analysis produces a more accurate PoD than traditionally used NOAEL/LOAEL methods in terms of thyroid toxicity induced by PTU. The BMDL and LOAEL for PTU-induced thyroid toxicity are 0.01 and 0.1 mg/kg bw. BMDL should be much lower and more protective than LOAEL in the risk assessment. In the light of the present study, we should consider applying BMD methods in more vigorous experimental designs, such as OECD protocols, to study PoD of thyroid toxicity. Besides, as multiple chemicals present in the environment can lead to thyroid toxicity, it will be necessary to investigate the mixture risk of thyroid toxicants.
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